Literature DB >> 31655975

Evaluation of health-related quality of life in adults with and without dyslipidaemia in rural areas of central China.

Hui Wu1,2,3, Huijun Li2, Haibin Li2, Yu Ding2,3, Chongjian Wang4, Guicheng Zhang2,5, Naijun Tang6,7, Weidong Wu8.   

Abstract

PURPOSE: Dyslipidaemia is a common chronic disease in China but is among the list of diseases treated by basic public health services. In this study, we aimed to use the European Quality of Life Five Dimension Five Level Scale (EQ-5D-5L) and visual analogue scale (VAS) to compare differences in health-related quality of life (HRQoL) between dyslipidaemic and non-dyslipidaemic individuals in rural China and to explore possible causes for the underlying differences.
METHODS: This study examined 10,115 participants from 22 rural communities in Xinxiang County, Henan Province, China. The study participants were interviewed between March and June 2017. Generalised linear and Tobit regression models were used to analyse factors affecting participants' HRQoL.
RESULTS: Of 10,115 participants, 4355 had dyslipidaemia. The mean utility index was 0.953 (standard deviation = 0.119). Pain/discomfort (20.83%) and problems with mobility (15.91%) and self-care (3.75%) were frequently reported. Regression models revealed that patients with low utility index scores were older, ex-smokers, non-tea drinkers, and less active, consumed less fruit, lived in areas with a low socioeconomic status; and were less educated. Patients also had poorer sleep quality and mental health scores and suffered from chronic diseases. Cohen's D effect size for age, sleep quality, non-communicable diseases, and depression was ≥ 0.4.
CONCLUSION: The prevalence rate of dyslipidaemia was 43.05%, and it was correlated with a lower HRQoL. Age, sleep quality, non-communicable diseases, and depression may be significant predictors of the utility index and VAS scores. Patients were unaware of the risks of dyslipidaemia caused by an unhealthy lifestyle.

Entities:  

Keywords:  Dyslipidaemia; EQ-5D-5L; HRQoL; Rural

Mesh:

Year:  2019        PMID: 31655975     DOI: 10.1007/s11136-019-02336-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  43 in total

1.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.

Authors:  Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson; Farhad Zangeneh; Michael A Bush
Journal:  Endocr Pract       Date:  2017-02-03       Impact factor: 3.443

2.  Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.

Authors:  Andrew Moran; Dongfeng Gu; Dong Zhao; Pamela Coxson; Y Claire Wang; Chung-Shiuan Chen; Jing Liu; Jun Cheng; Kirsten Bibbins-Domingo; Yu-Ming Shen; Jiang He; Lee Goldman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-04

3.  Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?

Authors:  Milad Karimi; John Brazier
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

4.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano
Journal:  Atherosclerosis       Date:  2016-09-01       Impact factor: 5.162

5.  Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project.

Authors:  Jordi Alonso; Montserrat Ferrer; Barbara Gandek; John E Ware; Neil K Aaronson; Paola Mosconi; Niels K Rasmussen; Monika Bullinger; Shunichi Fukuhara; Stein Kaasa; Alain Leplège
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

6.  The prevalence, awareness, treatment and control of dyslipidemia among adults in China.

Authors:  Ling Pan; Zhenhua Yang; Yue Wu; Rui-Xing Yin; Yunhua Liao; Jinwei Wang; Bixia Gao; Luxia Zhang
Journal:  Atherosclerosis       Date:  2016-02-27       Impact factor: 5.162

7.  A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012-2015.

Authors:  Zengwu Wang; Xin Wang; Guang Hao; Zuo Chen; Linfeng Zhang; Lan Shao; Ye Tian; Ying Dong; Congyi Zheng; Yuting Kang; Runlin Gao
Journal:  Int J Cardiol       Date:  2018-10-25       Impact factor: 4.164

8.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.

Authors:  M F Janssen; A Simon Pickard; Dominik Golicki; Claire Gudex; Maciej Niewada; Luciana Scalone; Paul Swinburn; Jan Busschbach
Journal:  Qual Life Res       Date:  2012-11-25       Impact factor: 4.147

9.  Changes in health-related quality of life of Chinese populations measured by the EQ-5D-3 L: a comparison of the 2008 and 2013 National Health Services Surveys.

Authors:  Qiang Yao; Chaojie Liu; Yaoguang Zhang; Ling Xu
Journal:  Health Qual Life Outcomes       Date:  2019-03-11       Impact factor: 3.186

Review 10.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

View more
  4 in total

1.  Health-Related Quality of Life and Its Related Factors in Survivors of Stroke in Rural China: A Large-Scale Cross-Sectional Study.

Authors:  Yong-Xia Mei; Zhen-Xiang Zhang; Hui Wu; Jian Hou; Xiao-Tian Liu; Sheng-Xiang Sang; Zhen-Xing Mao; Wei-Hong Zhang; Dong-Bin Yang; Chong-Jian Wang
Journal:  Front Public Health       Date:  2022-04-05

2.  Health-related quality of life and its related factors in coronary heart disease patients: results from the Henan Rural Cohort study.

Authors:  Yong-Xia Mei; Hui Wu; Huan-Yun Zhang; Jian Hou; Zhen-Xiang Zhang; Wei Liao; Xiao-Tian Liu; Sheng-Xiang Sang; Zhen-Xing Mao; Dong-Bin Yang; Chong-Jian Wang; Wei-Hong Zhang
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

3.  Independent and combined effects of sleep quality and night sleep duration on health-related quality of life in rural areas: a large-scale cross-sectional study.

Authors:  Wei Liao; Xiaotian Liu; Ning Kang; Lulu Wang; Zhihan Zhai; Jing Yang; Xueyan Wu; Yongxia Mei; Shengxiang Sang; Chongjian Wang; Yuqian Li
Journal:  Health Qual Life Outcomes       Date:  2022-02-21       Impact factor: 3.186

4.  Resveratrol Protects SH-SY5Y Cells Against Oleic Acid-Induced Glucolipid Metabolic Dysfunction and Cell Injuries Via the Wnt/β-Catenin Signalling Pathway.

Authors:  Jing-Xian Xu; Ke Fang; Xin-Ran Gao; Sen Liu; Jin-Fang Ge
Journal:  Neurochem Res       Date:  2021-07-14       Impact factor: 3.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.